跳至主要内容
临床试验/NCT02885922
NCT02885922招募中不适用

The Effects of add-on Anti-diabetic Drugs on Inflammation and Energy Homeostasis in Type 2 Diabetic Patients

Taichung Veterans General Hospital1 个研究点 分布在 1 个国家目标入组 6,000 人开始时间: 2016年9月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
6,000
试验地点
1
主要终点
HbA1c

研究概览

简要总结

Recently, there are some new classes of anti-diabetic drugs availible in Taiwan. In this study, we will observe the change in inflammation and energy homeostasis in type 2 diabetic outpatient, who receiving a new anti-diabetic drugs.

详细描述

Recently, there are some new classes of anti-diabetic drugs availible in Taiwan. However, the effects of these anti-diabetic drugs should be further evaluated. Specially, the effects on inflammation and energy homeostasis are still not well assessed. In this study, we will observe the change in inflammation and energy homeostasis in type 2 diabetic outpatient, who receiving a new anti-diabetic drugs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetic outpatient

排除标准

  • Refusal of anti-diabetic drugs
  • Preganacy

结局指标

主要结局

HbA1c

时间窗: 3 months

次要结局

  • Fasting glucose(3 months)
  • Brain-Derived Neurotrophic Factor (BDNF)(3 months)
  • Body-composition(3 months)
  • Vascular Cell Adhesion Molecule 1 (VCAM-1)(3 months)
  • Ankle-Brachial Index (ABI)(12 months)
  • Hypoglycemia(3 months)
  • Orexin-A(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验